[HTML][HTML] Critical success factors for high routine immunization performance: A case study of Senegal

…, AS Ellis, DM Gueye, D Mapatano, PS Mboup… - Vaccine: X, 2023 - Elsevier
Background The essential components of a vaccine delivery system are well-documented,
but robust evidence is lacking on how policies and implementation strategies are …

[HTML][HTML] Performance du GeneXpert MTB/RIF® dans le diagnostic de la tuberculose extra-pulmonaire à Dakar: 2010-2015

…, A Thiam, AN Diawara, S Mboup… - The Pan African …, 2016 - ncbi.nlm.nih.gov
… , 1 Aliou Thiam, 1 Awa Ndiaye Diawara, 1 Souleymane Mboup, 1 et Aissatou Gaye Diallo
1 … Aissatou Gaye Diallo et Souleymane Mboup ont supervisé les travaux du début à la fin. …

[HTML][HTML] Évolution de l'implication des communautés dans la riposte à Ebola

E Mamadou Mbaye 1, S Kone 2, O Ka 3, S Mboup 1 - Santé publique, 2017 - cairn.info
Contexte : L’implication des communautés est l’une des bonnes pratiques de la lutte contre
Ebola. Elle a fait ses preuves dans d’autres contextes et fut mise en œuvre en Guinée …

[HTML][HTML] A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa

…, K Marsh, JP Daily, D Ndiaye, O Sarr, S Mboup… - PloS one, 2011 - journals.plos.org
Background The reservoir of Plasmodium infection in humans has traditionally been defined
by blood slide positivity. This study was designed to characterize the local reservoir of …

Geographical distribution of HIV-1 group O viruses in Africa

M Peeters, A Gueye, S Mboup, F Bibollet-Ruche… - Aids, 1997 - journals.lww.com
Objective: To determine to what extent HIV-1 group O strains are present in different African
countries. Materials and methods: A total of 14 682 samples of sera from a range of patients …

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

…, I Lanièce, CT Kane, F Liégeois, L Vergne, S Mboup… - Aids, 2002 - journals.lww.com
Objective To study the feasibility, effectiveness, adherence, toxicity and viral resistance in
an African government HAART initiative. Methods A prospective observational cohort study …

Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers

…, G Chen, F Shen, WY Lin, S Mboup… - Journal of medical …, 2004 - Wiley Online Library
The role of quantitative viral load in development of hepatocellular carcinoma (HCC) among
chronic hepatitis B virus (HBV) carriers was evaluated using real‐time PCR (TaqMan PCR), …

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2

…, KU Travers, A Gueye-Ndiaye, S Mboup… - The Journal of …, 1999 - academic.oup.com
Human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV type 1 (HIV-1),
but the mechanisms underlying this difference have not been defined. We developed an …

Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo

SJ Popper, AD Sarr, A Guèye-Ndiaye, S Mboup… - Journal of …, 2000 - Am Soc Microbiol
Levels of virus in the plasma are closely related to the pathogenicity of human immunodeficiency
virus type 1 (HIV-1). HIV-2 is much less pathogenic than HIV-1, and infection with HIV-2 …

[HTML][HTML] Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo …

…, BP Ndiaye, CT Ndour, S Mboup… - The Lancet Infectious …, 2020 - thelancet.com
Background During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus,
about 20% of cases were reported in children. This study is the first, to our knowledge, to …